Antimitotic Agents: all 5,052 studies that test it

Page 11 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Cisplatin vs Paclitaxel for Triple Negative Breast CancerCompletedNCT01982448Phase 2Results posted
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)CompletedNCT01964430Phase 3Results posted
• Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT01962948Phase 1/2Results posted
• Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCompletedNCT01962103Phase 1/2Results posted
• Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT01961544Phase 4Results posted
• Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By SurgeryTerminatedNCT01958580Not applicableResults posted
• Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT01953003Phase 3Results posted
• An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid TumorsCompletedNCT01945710Phase 1Results posted
• BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid TumorsCompletedNCT01938846Phase 1Results posted
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTerminatedNCT01938833Phase 1/2Results posted
• Effect of Colchicine for the Palliative Management of Hepatocellular CarcinomaCompletedNCT01935700Phase 2Results posted
• Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial MetastasesTerminatedNCT01934894Phase 2Results posted
• Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal CancerCompletedNCT01932697Phase 2Results posted
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT01925612Phase 2Results posted
• S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT01925131Phase 1Results posted
• Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast CancerTerminatedNCT01912963Phase 2Results posted
• Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerCompletedNCT01908101Phase 2Results posted
• Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancerTerminatedNCT01897441Not applicableResults posted
• Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDACompletedNCT01893801Phase 1/2Results posted
• A Study Of PF-06263507 In Patients With Advanced Solid TumorsTerminatedNCT01891669Phase 1Results posted
• Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast CancerTerminatedNCT01891357Phase 2Results posted
• Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute LeukemiaTerminatedNCT01887587Phase 1Results posted
• Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsCompletedNCT01882985Phase 2Results posted
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)CompletedNCT01881230Phase 2/3Results posted
• Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced SarcomaCompletedNCT01879085Phase 1/2Results posted
• A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerTerminatedNCT01876251Phase 1Results posted
• Phase II Trial for Large ER-Negative Breast CancersCompletedNCT01869192Phase 2Results posted
• Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway SignalingCompletedNCT01868022Phase 1Results posted
• Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid TumorsCompletedNCT01862328Phase 1Results posted
• Therapy for Children With Advanced Stage NeuroblastomaCompletedNCT01857934Phase 2Results posted
• Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast CancerCompletedNCT01855828Phase 2Results posted
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)CompletedNCT01853748Phase 2Results posted
• Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTerminatedNCT01851174Phase 2Results posted
• Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate CancerTerminatedNCT01845792Phase 2Results posted
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaCompletedNCT01839799Phase 2Results posted
• Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsCompletedNCT01831089Phase 1Results posted
• Eribulin in HER2 Negative Metastatic BrCaCompletedNCT01827787Phase 2Results posted
• Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast CancerCompletedNCT01827163Phase 2Results posted
• Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaCompletedNCT01827111Phase 2Results posted
• Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung CancerCompletedNCT01824901Phase 1/2Results posted
• An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid TumorsTerminatedNCT01822756Phase 1Results posted
• Abraxane/BevacizumabTerminatedNCT01821859Phase 2Results posted
• Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCaCompletedNCT01796197Phase 2Results posted
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer PatientsCompletedNCT01764022Phase 3Results posted
• A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01763645Phase 3Results posted
• Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCCompletedNCT01757288Phase 1/2Results posted
• Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal AdenocarcinomaCompletedNCT01757171Phase 2Results posted
• Colchicine and CRP in Atrial Fibrillation and AF AblationCompletedNCT01755949Phase 2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System TumorsCompletedNCT01751308Phase 1/2Results posted
• Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.CompletedNCT01750281Phase 2Results posted
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerCompletedNCT01750073Phase 2Results posted
• Schedules of Nab-Paclitaxel in Metastatic Breast CancerCompletedNCT01746225Phase 2Results posted
• A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.TerminatedNCT01732640Phase 1/2Results posted
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCompletedNCT01730833Phase 2Results posted
• Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasCompletedNCT01730586Phase 2Results posted
• Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT01718353Phase 2Results posted
• Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01716715Phase 2Results posted
• Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.CompletedNCT01715233Phase 2Results posted
• Anti-inflammatory Effects of Colchicine in PCICompletedNCT01709981Phase 4Results posted
• Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast CancerCompletedNCT01705691Phase 2Results posted
• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)CompletedNCT01704287Phase 2Results posted
• Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
• Endoscopic Abraxane Injection Into Pancreatic CystsTerminatedNCT01698710Not applicableResults posted
• Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerCompletedNCT01688609Phase 2Results posted
• Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical CancerCompletedNCT01676818Phase 2Results posted
• Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
• Dose-finding Study in Platinum-Resistant Ovarian CancerCompletedNCT01653912Phase 1/2Results posted
• CP-751,871 In Combination With Docetaxel In Advance Non-hematologic MalignanciesCompletedNCT01653158Phase 1Results posted
• Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.CompletedNCT01652469Phase 3Results posted
• Cabazitaxel and Radiation For Patients With Prostate CancerTerminatedNCT01650285Phase 2Results posted
• A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell LymphomaCompletedNCT01649856Phase 3Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01646762Phase 2Results posted
• Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)CompletedNCT01642004Phase 3Results posted
• Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal AdenocarcinomaTerminatedNCT01639131Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung CancerCompletedNCT01620190Phase 2Results posted
• Bristol Bladder TrialCompletedNCT01616875Phase 2Results posted
• Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland CancerCompletedNCT01613768Phase 2Results posted
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryCompletedNCT01612351Phase 2Results posted
• External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate CancerTerminatedNCT01603420Phase 2/3Results posted
• Drug Interaction Study of Colchicine and TheophyllineCompletedNCT01601132Phase 4Results posted
• Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast CancerCompletedNCT01596751Phase 1/2Results posted
• Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2CompletedNCT01593020Phase 2Results posted
• Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent GlioblastomaTerminatedNCT01582152Phase 1/2Results posted
• Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerTerminatedNCT01579578Phase 2Results posted
• Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin LymphomaCompletedNCT01578967Not applicableResults posted
• A Study of Ramucirumab and Docetaxel in Participants With Solid TumorsCompletedNCT01567163Phase 2Results posted
• Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck CancerCompletedNCT01566435Phase 2Results posted
• Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerCompletedNCT01565499Phase 2Results posted
• A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerCompletedNCT01565083Phase 2Results posted
• Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate CancerTerminatedNCT01558492Phase 2Results posted
• Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 2Results posted
• Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor MalignanciesCompletedNCT01554371Phase 1/2Results posted
• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerCompletedNCT01547741Phase 3Results posted
• Metronomic Therapy in Patients With Metastatic MelanomaTerminatedNCT01542255Phase 2Results posted
• Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by SurgeryTerminatedNCT01533207Phase 3Results posted
• Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast CancerCompletedNCT01527487Phase 2Results posted
• Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT01527149Phase 2Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerActive, not recruitingNCT01525966Phase 2Results posted

← Antimitotic Agents overview